Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Health Care
Therapeutics
Medical
Biopharma
Date founded
2016
Funding rounds raised
Total raised
$73M
from 12 investors over 12 rounds
I
Immune-Onc Therapeutics raised $25M on January 5, 2023
Investors: 深圳前海勤智国际资本管理有限公司 and BOCOM International
I
Immune-Onc Therapeutics raised $73M on March 30, 2021
Investors: Octagon Capital Advisors, Northern Light Venture Capital, The Leukemia & Lymphoma Society, Vivo Capital and Oceanpine Capital
I
Immune-Onc Therapeutics raised $2.1M on August 4, 2020
Investors: National Cancer Institute
I
Immune-Onc Therapeutics raised $33M on September 18, 2018
Investors: Vivo Capital and Northern Light Venture Capital
I
Immune-Onc Therapeutics raised undisclosed on May 1, 2018
Investors: Loyal Valley Capital
I
Immune-Onc Therapeutics raised $7M on September 1, 2016
Investors: CLI Ventures